Insider Cluster (4 insiders) ·Filed Feb 27, 2026

UTHR

UNITED THERAPEUTICS Corp
NEUTRAL
Impact 3/10
Horizonimmediate Processed7mo ago
Insider cluster: 2 insiders, $127K total
Actionable Insight • Neutral

The activity is routine and not materially bearish — the large option exercises are non-cash events, and the open-market sales are minimal relative to company size. No signal of distress or negative sentiment from insiders.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
UTHR ▲ +15.39% at T+60d
NEUTRAL call ✓ call won +15.39% · α vs SPY +6.00% · entry $501.29 → $578.43
Entry anchored
Feb 26, 03:59 PM ET
via exchange tick
T+1d
+1.90%
call +1.90% · α +1.85%
$510.82
settled 7mo ago
T+5d
-5.14%
call -5.14% · α -3.16%
$475.52
settled 7mo ago
T+20d
+4.29%
call +4.29% · α +11.84%
$522.78
settled 6mo ago
T+60d
+15.39%
call +15.39% · α +6.00%
$578.43
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

A recent insider trading cluster at United Therapeutics includes two open-market share sales totaling $127K and two derivative exercises worth $1.5M. The CEO and another executive exercised options but did not sell the underlying shares, while two other insiders sold small amounts in the open market.

Key Financial Metrics

Direction
selling
Total Value
$127.4K
Insiders
4

Key Facts

  • CEO Martine Rothblatt exercised options for 9,500 shares at $146.03 (value: $1.39M), a non-cash transaction.
  • Christopher Causey exercised options for 1,000 shares at $119.76 (value: $119,760), also non-cash.
  • Malcolm Jan sold 50 shares for $25,460 and Judy Olian sold 200 shares for $101,910 — both open-market sales.
  • Total open-market selling: $127,370 (<0.001% of $22.5B market cap).
  • No open-market selling by the CEO or C-suite beyond routine transactions.

Financial Impact

$127,370 in open-market sales and $1.51M in derivative exercises (non-cash)

insider ownershippotential future dilution

Risk Factors

  • Derivative exercises may lead to future selling to cover taxes or diversify holdings, though not indicated here.
  • Perception risk if media mischaracterizes option exercises as insider selling.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (4 trades, 7d window)cluster-UTHR-1772574371439
91 reports for UTHR
Performance horizon
80% Hit rate 4 of 5 directional calls best @ T+60▲ +5.53%Feb 25, 2026
Filters
Rows
Reports for UTHR — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
NEUTRAL ★ 2/10
$500.35 $497.31▼ −0.61%▼ −2.72%$573.51 (+14.62%)
Sep 11, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$497.11 $494.63▼ −0.50%▼ −0.28%$573.51 (+15.37%)
Sep 10, 2026
22d ago
Insider Cluster
MIXED ★ 4/10
$503.86 $497.27▼ −1.31%▼ −0.81%$573.51 (+13.82%)
Sep 9, 2026
23d ago
Insider Cluster
NEUTRAL ★ 3/10
$506.82 $498.48▼ −1.65%▼ −0.99%$573.51 (+13.16%)
Sep 4, 2026
28d ago
Insider Cluster
NEUTRAL ★ 2/10
$487.61 $502.70▲ +3.09%▲ +4.30%$573.51 (+17.62%)
Sep 3, 2026
29d ago
Insider Cluster
NEUTRAL ★ 2/10
$488.16 $497.11▲ +1.83%▲ +2.98%$573.51 (+17.48%)
Aug 28, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$515.46 $487.61▼ −5.40%▼ −5.51%$573.51 (+11.26%)
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$527.91 $492.02▼ −6.80%▼ −6.03%$573.51 (+8.64%)
Aug 26, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$516.68 $492.02▼ −4.77%▼ −4.65%$573.51 (+11.00%)
Aug 25, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$516.68 $492.02▼ −4.77%▼ −4.65%$573.51 (+11.00%)
Showing 10 of 91

US Market Status

Market Open — Closes in 6h 26m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Mar 3, 2026